SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Nowak Maciej) "

Sökning: WFRF:(Nowak Maciej)

  • Resultat 1-5 av 5
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Jung, Christian, et al. (författare)
  • A comparison of very old patients admitted to intensive care unit after acute versus elective surgery or intervention
  • 2019
  • Ingår i: Journal of critical care. - : W B SAUNDERS CO-ELSEVIER INC. - 0883-9441 .- 1557-8615. ; 52, s. 141-148
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: We aimed to evaluate differences in outcome between patients admitted to intensive care unit (ICU) after elective versus acute surgery in a multinational cohort of very old patients (80 years; VIP). Predictors of mortality, with special emphasis on frailty, were assessed.Methods: In total, 5063 VIPs were induded in this analysis, 922 were admitted after elective surgery or intervention, 4141 acutely, with 402 after acute surgery. Differences were calculated using Mann-Whitney-U test and Wilcoxon test. Univariate and multivariable logistic regression were used to assess associations with mortality.Results: Compared patients admitted after acute surgery, patients admitted after elective surgery suffered less often from frailty as defined as CFS (28% vs 46%; p < 0.001), evidenced lower SOFA scores (4 +/- 5 vs 7 +/- 7; p < 0.001). Presence of frailty (CFS >4) was associated with significantly increased mortality both in elective surgery patients (7% vs 12%; p = 0.01), in acute surgery (7% vs 12%; p = 0.02).Conclusions: VIPs admitted to ICU after elective surgery evidenced favorable outcome over patients after acute surgery even after correction for relevant confounders. Frailty might be used to guide clinicians in risk stratification in both patients admitted after elective and acute surgery. 
  •  
2.
  • Małyszko, Jolanta, et al. (författare)
  • Do we know more about hypertension in Poland after the May Measurement Month 2017? - Europe
  • 2019
  • Ingår i: European Heart Journal, Supplement. - : Oxford University Press (OUP). - 1520-765X .- 1554-2815. ; 21, s. 97-100
  • Forskningsöversikt (refereegranskat)abstract
    • Elevated blood pressure (BP) is a worldwide burden, leading to over 10 million deaths yearly. May Measurement Month (MMM) is a global initiative organized by the International Society of Hypertension aimed at raising awareness of hypertension and the need for BP screening. An opportunistic cross-sectional survey of volunteers aged ≥18 was carried out in May 2017. BP measurement, the definition of hypertension and statistical analysis followed the globally approved MMM17 Study Protocol. In Poland 5834 (98.9%, Caucasian) individuals were screened. After multiple imputation, 2601 (35.3%) had hypertension. Of individuals not receiving anti-hypertensive medication, 976 (20.6%) were hypertensive. Of individuals receiving anti-hypertensive medication, 532 (49.1%) had uncontrolled BP. In the crude screened group, 81.4% declared to not receive any anti-hypertensive treatment, while the remaining 18.6% were on such medications. In overweight and obese patients both systolic and diastolic BP were significantly higher than in normal weight and underweight subjects. In addition, BP measured on Sundays was significantly lower than on Mondays. MMM17 was one of the largest recent BP screening campaigns in Poland. We found that over 1/3 of participants were hypertensive. Almost half of the treated subjects had uncontrolled BP. These results suggest that opportunistic screening can identify substantial numbers with raised BP.
  •  
3.
  • Marto, João Pedro, et al. (författare)
  • Safety and Outcome of Revascularization Treatment in Patients With Acute Ischemic Stroke and COVID-19: The Global COVID-19 Stroke Registry.
  • 2023
  • Ingår i: Neurology. - 1526-632X. ; 100:7
  • Tidskriftsartikel (refereegranskat)abstract
    • COVID-19-related inflammation, endothelial dysfunction, and coagulopathy may increase the bleeding risk and lower the efficacy of revascularization treatments in patients with acute ischemic stroke (AIS). We aimed to evaluate the safety and outcomes of revascularization treatments in patients with AIS and COVID-19.This was a retrospective multicenter cohort study of consecutive patients with AIS receiving intravenous thrombolysis (IVT) and/or endovascular treatment (EVT) between March 2020 and June 2021 tested for severe acute respiratory syndrome coronavirus 2 infection. With a doubly robust model combining propensity score weighting and multivariate regression, we studied the association of COVID-19 with intracranial bleeding complications and clinical outcomes. Subgroup analyses were performed according to treatment groups (IVT-only and EVT).Of a total of 15,128 included patients from 105 centers, 853 (5.6%) were diagnosed with COVID-19; of those, 5,848 (38.7%) patients received IVT-only and 9,280 (61.3%) EVT (with or without IVT). Patients with COVID-19 had a higher rate of symptomatic intracerebral hemorrhage (SICH) (adjusted OR 1.53; 95% CI 1.16-2.01), symptomatic subarachnoid hemorrhage (SSAH) (OR 1.80; 95% CI 1.20-2.69), SICH and/or SSAH combined (OR 1.56; 95% CI 1.23-1.99), 24-hour mortality (OR 2.47; 95% CI 1.58-3.86), and 3-month mortality (OR 1.88; 95% CI 1.52-2.33). Patients with COVID-19 also had an unfavorable shift in the distribution of the modified Rankin score at 3 months (OR 1.42; 95% CI 1.26-1.60).Patients with AIS and COVID-19 showed higher rates of intracranial bleeding complications and worse clinical outcomes after revascularization treatments than contemporaneous non-COVID-19 patients receiving treatment. Current available data do not allow direct conclusions to be drawn on the effectiveness of revascularization treatments in patients with COVID-19 or to establish different treatment recommendations in this subgroup of patients with ischemic stroke. Our findings can be taken into consideration for treatment decisions, patient monitoring, and establishing prognosis.The study was registered under ClinicalTrials.gov identifier NCT04895462.
  •  
4.
  • Machaczka, Maciej, et al. (författare)
  • Association between P-glycoprotein and lymphoid antigen expression on myeloblasts versus therapy response and survival in de novo acute myeloid leukemia : long-term follow-up results
  • 2012
  • Ingår i: Medical Oncology. - : Springer Science and Business Media LLC. - 1357-0560 .- 1559-131X. ; 29:3, s. 2070-2076
  • Tidskriftsartikel (refereegranskat)abstract
    • P-glycoprotein (PGP) over-expression on malignant cells is associated with poor prognosis and treatment outcome due to the development of a multidrug resistance phenotype. In this study, we analyzed the correlation between expression of PGP and lymphoid antigens (Ly) on leukemic myeloblasts versus response to therapy and survival in acute myeloid leukemia (AML). Fifty-one consecutive patients, aged 16–75 (median age 44.6 years), diagnosed with de novo AML between 1997 and 2000, and who received at least one induction chemotherapy course, were enrolled in the study. Expression of PGP on ≥10% of the myeloblasts (PGP+AML) at the time of diagnosis was observed in 21 patients (41%). The complete remission rate did not differ between PGP+ (13/21) and PGP− (20/30) patients (62 vs. 67%). Twelve of the 51 patients (24%) were still alive after a median follow-up time of 11.5 years (range 10.7–13.1). The Ly+AML patients showed significantly better overall survival compared with Ly−AML patients (8/18 vs. 4/33 patients alive at the last follow-up, P = 0.003). The subgroup of patients with co-expression of PGP and Ly also showed better overall survival compared with PGP+AML patients without Ly expression (4/8 vs. 0/13 patients alive at the last follow-up; P = 0.04). Our results suggest that expression of lymphoid antigens on PGP+ myeloblasts in AML can positively affect survival in AML patients, mainly due to a decreased relapse risk and better survival. Although the small number of patient may be perceived as a limitation of the study, the long follow-up period strengthens its value. Further prospective trials are needed to obtain more information concerning the association between PGP and lymphoid antigens in AML, which would put our results in their ultimate proper context.
  •  
5.
  • Pielaszkiewicz, Jolanta Maria, 1985- (författare)
  • On the asymptotic spectral distribution of random matrices : closed form solutions using free independence
  • 2013
  • Licentiatavhandling (övrigt vetenskapligt/konstnärligt)abstract
    • The spectral distribution function of random matrices is an information-carrying object widely studied within Random matrix theory. In this thesis we combine the results of the theory together with the idea of free independence introduced by Voiculescu (1985).Important theoretical part of the thesis consists of the introduction to Free probability theory, which justifies use of asymptotic freeness with respect to particular matrices as well as the use of Stieltjes and R-transform. Both transforms are presented together with their properties.The aim of thesis is to point out characterizations of those classes of the matrices, which have closed form expressions for the asymptotic spectral distribution function. We consider all matrices which can be decomposed to the sum of asymptotically free independent summands.In particular, explicit calculations are performed in order to illustrate the use of asymptotic free independence to obtain the asymptotic spectral distribution for a matrix Q and generalize Marcenko and Pastur (1967) theorem. The matrix Q is defined as where Xi is p × n matrix following a matrix normal distribution, Xi ~ Np,n(0, \sigma^2I, I).Finally, theorems pointing out classes of matrices Q which lead to closed formula for the asymptotic spectral distribution will be presented. Particularly, results for matrices with inverse Stieltjes transform, with respect to the composition, given by a ratio of polynomials of 1st and 2nd degree, are given.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-5 av 5
Typ av publikation
tidskriftsartikel (3)
forskningsöversikt (1)
licentiatavhandling (1)
Typ av innehåll
refereegranskat (4)
övrigt vetenskapligt/konstnärligt (1)
Författare/redaktör
Kotfis, Katarzyna (1)
Nilsson, Annika (1)
Jood, Katarina, 1966 (1)
Adamik, Barbara (1)
Hägglund, Hans (1)
Tiu, Cristina (1)
visa fler...
Mikulik, Robert (1)
Walther, Sten (1)
Wood, James (1)
Balasubramaniam, M (1)
Ntaios, George (1)
Nordanstig, Annika, ... (1)
Cortegiani, Andrea (1)
Schuster, Michael (1)
Jansky, Petr (1)
Michel, Philippe (1)
Stolze, Lotte J (1)
Zini, Andrea (1)
Baumgartner, Philipp (1)
Zedde, Marialuisa (1)
Pezzini, Alessandro (1)
Cereda, Carlo W (1)
Wegener, Susanne (1)
Michel, Patrik (1)
Gentile, Mauro (1)
Arnold, Marcel (1)
Gensicke, Henrik (1)
Ribeiro, Luis (1)
Brorsson, Camilla (1)
Slowik, Agnieszka (1)
Montaner, Joan (1)
de Geer, Lina (1)
Castro, Pedro (1)
Joannidis, Michael (1)
Cecconi, Maurizio (1)
Marcheselli, Simona (1)
Fumagalli, Roberto (1)
Artigas, Antonio (1)
Andersen, Finn H. (1)
Klepstad, Pal (1)
Schefold, Joerg C. (1)
Szczeklik, Wojciech (1)
Lemmens, Robin (1)
Małyszko, Jolanta (1)
Bergstrom, Anna (1)
Banach, Maciej (1)
Jozwiak, Jacek (1)
Dieperink, Willem (1)
Xia, Xin (1)
Beaney, Thomas (1)
visa färre...
Lärosäte
Uppsala universitet (2)
Karolinska Institutet (2)
Göteborgs universitet (1)
Linköpings universitet (1)
Lunds universitet (1)
Linnéuniversitetet (1)
Språk
Engelska (5)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (4)
Naturvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy